다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of psychiatric research, v.58, 2014년, pp.84 - 88
Yang, Y.W. , Hsieh, T.F. , Yu, C.H. , Huang, Y.S. , Lee, C.C. , Tsai, T.H.
AI-Helper
Background: This nationwide population-based study investigated the risk of Parkinson's disease (PD) after zolpidem use in patients with sleep disturbance using the National Health Insurance Research Database (NHIRD) in Taiwan. Material and methods: In total, 59,548 adult patients newly diagnosed wi...
J Clin Neurosci Chen 15 955 2008 10.1016/j.jocn.2007.07.082 Zolpidem improves akinesia, dystonia and dyskinesia in advanced Parkinson's disease
Parkinsonism Relat Disord Chen 18 506 2012 10.1016/j.parkreldis.2012.01.014 Parkinson's disease and risk of hip fracture: an 8-year follow-up study in Taiwan
Pharmacoepidemiol Drug Saf Cheng 20 236 2011 10.1002/pds.2087 Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan
Health Policy Chiang 39 225 1997 10.1016/S0168-8510(96)00877-9 Taiwan's 1995 health care reform
PharmacoEconomics Chilcott 10 Suppl. 1 1 1996 10.2165/00019053-199600101-00003 The socioeconomic impact of insomnia: an overview
PLoS One Chung 8 e67459 2013 10.1371/journal.pone.0067459 Zolpidem use and the risk of Injury: a population-based follow-up study
N Engl J Med Cohen 350 949 2004 10.1056/NEJM200402263500922 Transient improvement of aphasia with zolpidem
Lancet Daniele 349 1222 1997 10.1016/S0140-6736(05)62416-6 Zolpidem in Parkinson's disease
Health Technol Assess Dundar 8 iii-x 1 2004 Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
Neurology Evidente 58 662 2002 10.1212/WNL.58.4.662 Zolpidem improves dystonia in “Lubag” or X-linked dystonia-Parkinsonism syndrome
BMJ Glass 331 1169 2005 10.1136/bmj.38623.768588.47 Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Clin Neurophysiol Hall 121 549 2010 10.1016/j.clinph.2009.11.084 GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke-a case report
Acta Neurol Taiwanica Huang 21 84 2012 Zolpidem improves neuropsychiatric symptoms and motor dysfunction in a patient with Parkinson's disease after deep brain stimulation
J Clin Psychiatry Huang 74 e433 2013 10.4088/JCP.12m08181 Relationship between zolpidem use and stroke risk: a Taiwanese population-based case-control study
Sleep Med Huang 14 1341 2013 10.1016/j.sleep.2013.07.017 Nonapnea sleep disorders are associated with subsequent ischemic stroke risk: a nationwide, population-based, retrospective cohort study
J Psychiatr Res Huang 54 116 2014 10.1016/j.jpsychires.2014.03.017 The association between zolpidem and infection in patients with sleep disturbance
Mayo Clin Proc Lai 89 589 2014 10.1016/j.mayocp.2014.01.021 Long-term use of zolpidem increases the risk of major injury: a population-based cohort study
Lancet Lavoisy 350 74 1997 10.1016/S0140-6736(05)66285-X Zolpidem in Parkinson's disease
Stroke Lee 42 48 2011 10.1161/STROKEAHA.110.597070 Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study
Sleep Med Liang 13 869 2012 10.1016/j.sleep.2012.02.005 Non-apnea sleep disorders will increase subsequent liver cancer risk-a nationwide population-based cohort study
Stroke Lin 39 2744 2008 10.1161/STROKEAHA.108.519090 Sudden sensorineural hearing loss increases the risk of stroke: a 5-year follow-up study
Aliment Pharmacol Ther Lu 22 739 2005 10.1111/j.1365-2036.2005.02664.x Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan
Eur Neuropsychopharmacol Mattila 21 500 2011 10.1016/j.euroneuro.2010.10.005 Insomnia medication: do published studies reflect the complete picture of efficacy and safety?
Medscape J Med Nassir Ghaemi 10 211 2008 Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder
Sleep Med Roy 11 462 2010 10.1016/j.sleep.2009.09.012 Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization
Br J Gen Pract Siriwardena 56 964 2006 GPs' attitudes to benzodiazepine and ‘Z-drug’ prescribing: a barrier to implementation of evidence and guidance on hypnotics
J Eval Clin Pract Siriwardena 16 731 2010 10.1111/j.1365-2753.2009.01186.x General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing
Diabetes Care Tseng 27 1605 2004 10.2337/diacare.27.7.1605 Mortality and causes of death in a national sample of diabetic patients in Taiwan
N Engl J Med Turner 358 252 2008 10.1056/NEJMsa065779 Selective publication of antidepressant trials and its influence on apparent efficacy
Parkinsonism Relat Disord Wahlqvist 18 753 2012 10.1016/j.parkreldis.2012.03.010 Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.